Investigating the molecular genetic, genomic, brain structural, and brain functional correlates of latent transdiagnostic dimensions of psychopathology across the lifespan: Protocol for a systematic review and meta-analysis of cross-sectional and longitudinal studies in the general population.
brain function
brain structure
externalising
genomic
internalising
lifespan
p-factor
psychopathology
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2022
2022
Historique:
received:
05
09
2022
accepted:
18
10
2022
entrez:
21
11
2022
pubmed:
22
11
2022
medline:
22
11
2022
Statut:
epublish
Résumé
Research using latent variable modelling has identified a superordinate general dimension of psychopathology, as well as several specific/lower-order transdiagnostic dimensions (e.g., internalising and externalising) within the meta-structure of psychiatric symptoms. These models can facilitate discovery in genetic and neuroscientific research by providing empirically derived psychiatric phenotypes, offering greater validity and reliability than traditional diagnostic categories. The prospective review outlined in this protocol aims to integrate and assess evidence from research investigating the biological correlates of general psychopathology and specific/lower-order transdiagnostic symptom dimensions. Cross-sectional and longitudinal studies investigating general population samples of any age group or developmental period will be included to capture evidence from across the lifespan. MEDLINE, Embase, and PsycINFO databases will be systematically searched for relevant literature. The review will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Eligibility criteria were designed to capture psychiatric genetic (i.e., molecular genetic and genomic) and neuroimaging (i.e., brain structural and brain functional) studies investigating latent transdiagnostic dimension(s) or structural model(s) of psychopathology across any age group. Studies which include or exclude participants based on clinical symptoms, disorders, or relevant risk factors (e.g., history of abuse, neglect, and trauma) will be excluded. Biometric genetic research (e.g., twin and family studies), candidate gene studies, neurophysiology studies, and other non-imaging based neuroscientific studies (e.g., post-mortem studies) will be excluded. Study quality and risk of bias will be assessed using the Joanna Briggs Checklist for Analytical Cross-Sectional Studies, the Joanna Briggs Checklist for Cohort Studies, and the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) system. Meta-analysis will be conducted if sufficient data is available. This protocol outlines the first systematic review to examine evidence from studies investigating the latent structure and underlying biology of psychopathology and to characterise these relationships developmentally across the lifespan. The prospective review will cover a broad range of statistical techniques and models used to investigate latent transdiagnostic dimensions of psychopathology, as well as a numerous genetic and neuroscientific methods. [https://www.crd.york.ac.uk/prospero/], identifier[CRD42021262717].
Sections du résumé
Background
UNASSIGNED
Research using latent variable modelling has identified a superordinate general dimension of psychopathology, as well as several specific/lower-order transdiagnostic dimensions (e.g., internalising and externalising) within the meta-structure of psychiatric symptoms. These models can facilitate discovery in genetic and neuroscientific research by providing empirically derived psychiatric phenotypes, offering greater validity and reliability than traditional diagnostic categories. The prospective review outlined in this protocol aims to integrate and assess evidence from research investigating the biological correlates of general psychopathology and specific/lower-order transdiagnostic symptom dimensions. Cross-sectional and longitudinal studies investigating general population samples of any age group or developmental period will be included to capture evidence from across the lifespan.
Methods and analysis
UNASSIGNED
MEDLINE, Embase, and PsycINFO databases will be systematically searched for relevant literature. The review will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Eligibility criteria were designed to capture psychiatric genetic (i.e., molecular genetic and genomic) and neuroimaging (i.e., brain structural and brain functional) studies investigating latent transdiagnostic dimension(s) or structural model(s) of psychopathology across any age group. Studies which include or exclude participants based on clinical symptoms, disorders, or relevant risk factors (e.g., history of abuse, neglect, and trauma) will be excluded. Biometric genetic research (e.g., twin and family studies), candidate gene studies, neurophysiology studies, and other non-imaging based neuroscientific studies (e.g., post-mortem studies) will be excluded. Study quality and risk of bias will be assessed using the Joanna Briggs Checklist for Analytical Cross-Sectional Studies, the Joanna Briggs Checklist for Cohort Studies, and the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) system. Meta-analysis will be conducted if sufficient data is available.
Discussion
UNASSIGNED
This protocol outlines the first systematic review to examine evidence from studies investigating the latent structure and underlying biology of psychopathology and to characterise these relationships developmentally across the lifespan. The prospective review will cover a broad range of statistical techniques and models used to investigate latent transdiagnostic dimensions of psychopathology, as well as a numerous genetic and neuroscientific methods.
Systematic review registration
UNASSIGNED
[https://www.crd.york.ac.uk/prospero/], identifier[CRD42021262717].
Identifiants
pubmed: 36405912
doi: 10.3389/fpsyt.2022.1036794
pmc: PMC9669375
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1036794Informations de copyright
Copyright © 2022 Hoy, Lynch, Waszczuk, Reppermund and Mewton.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Abnorm Psychol. 2017 May;126(4):454-477
pubmed: 28333488
JAMA Psychiatry. 2015 Apr;72(4):305-15
pubmed: 25651064
J Pers. 2021 Oct;89(5):915-932
pubmed: 33550639
Neuropsychobiology. 2020;79(4-5):270-283
pubmed: 31340207
Lancet Psychiatry. 2022 Feb;9(2):137-150
pubmed: 35026139
Allergy. 2009 May;64(5):669-77
pubmed: 19210357
Psychol Bull. 2017 Feb;143(2):142-186
pubmed: 28004947
BMC Med Res Methodol. 2018 May 21;18(1):44
pubmed: 29783954
Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 May;2(4):310-317
pubmed: 28713866
Am J Psychiatry. 2017 Jul 1;174(7):676-685
pubmed: 28320224
Perspect Psychol Sci. 2019 May;14(3):419-436
pubmed: 30844330
J Med Libr Assoc. 2018 Oct;106(4):531-541
pubmed: 30271302
Am J Psychiatry. 2018 Sep 1;175(9):831-844
pubmed: 29621902
Psychol Med. 2010 Feb;40(2):273-88
pubmed: 19515267
Arch Gen Psychiatry. 1999 Oct;56(10):921-6
pubmed: 10530634
Annu Rev Clin Psychol. 2021 May 7;17:83-108
pubmed: 33577350
Environ Int. 2018 Dec;121(Pt 1):1027-1031
pubmed: 30166065
Neuropsychopharmacology. 2020 Jun;45(7):1083-1085
pubmed: 32109934
Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
Neurosci Biobehav Rev. 2018 Jan;84:151-161
pubmed: 29180258
World Psychiatry. 2021 Feb;20(1):57-63
pubmed: 33432749
Dev Psychopathol. 2013 Nov;25(4 Pt 2):1215-24
pubmed: 24342836
Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 May;6(5):508-517
pubmed: 33229246
Clin Psychol Sci. 2022 Mar;10(2):259-278
pubmed: 35425668
Am J Psychiatry. 2019 May 1;176(5):376-387
pubmed: 30845820
Clin Psychol Sci. 2014 Mar;2(2):119-137
pubmed: 25360393
Clin Psychol Sci. 2022 Mar;10(2):279-284
pubmed: 35444863
Annu Rev Clin Psychol. 2020 May 7;16:75-98
pubmed: 32040926
BMC Med. 2013 May 14;11:126
pubmed: 23672542
Dev Psychopathol. 2008 Summer;20(3):745-74
pubmed: 18606030
Dialogues Clin Neurosci. 2020 Mar;22(1):51-63
pubmed: 32699505
Br J Anaesth. 2019 Nov;123(5):554-559
pubmed: 31558313
Neuropsychopharmacology. 2019 Aug;44(9):1518-1523
pubmed: 30982060
Ann Neurosci. 2016 Mar;23(1):3-5
pubmed: 27536015
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Biol Psychiatry. 2007 May 1;61(9):1017-8
pubmed: 17434010
Psychol Med. 2018 Aug;48(11):1759-1774
pubmed: 29198204
Transl Psychiatry. 2018 Aug 8;8(1):145
pubmed: 30089819
J Am Acad Child Adolesc Psychiatry. 2016 Aug;55(8):647-56
pubmed: 27453078
J Am Acad Child Adolesc Psychiatry. 2016 Feb;55(2):93-8
pubmed: 26802775
J Abnorm Psychol. 2020 Feb;129(2):143-161
pubmed: 31804095
Lancet. 2013 Apr 20;381(9875):1371-1379
pubmed: 23453885
J Abnorm Psychol. 2012 Nov;121(4):971-7
pubmed: 22845652
Clin Psychol Rev. 2021 Jul;87:102036
pubmed: 33992846
Evid Based Ment Health. 2020 May;23(2):83-87
pubmed: 32139442
World Psychiatry. 2020 Jun;19(2):151-172
pubmed: 32394571
Clin Psychol Sci. 2017;5(5):880-889
pubmed: 29057170
Lancet. 2013 Apr 20;381(9875):1339-1341
pubmed: 23453886
Psychol Monogr. 1966;80(7):1-37
pubmed: 5968338
Harv Rev Psychiatry. 2017 Sep/Oct;25(5):195-197
pubmed: 28885277